2 Results for "

HIV-1 integrase catalytic core domain

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "HIV-1 integrase catalytic core domain" in MCE Product Catalog:

Cat. No.: HY-153094
CAS No.: 1643876-33-8
Purity:  99.09%
Target:  

HIV HIV Integrase

Research Areas:  

Infection

BDM-2 is an IN-LEDGF allosteric inhibitor (INLAI) of HIV-1 integrase (IN refers to integrase) (IC50=47 nM) with potent anti-Retroviral (ARV) activity. BDM-2 shows IN multimerization activation effect with an AC50 value of 20 nM. BDM-2 blocks the interaction between the catalytic core domain of IN (IN-CCD) and the Integrase binding domain of LEDGF/p75 (IBD), with an IC50 value of 0.15 μM. BDM-2 exhibits highly selective and favorable cytotoxicity .
loading...
    loading...
Cat. No.: HY-182277
CAS No.: 1392118-63-6
Target:  

HIV Integrase HIV

Research Areas:  

Infection

GSK-1264 is an HIV-1 integrase inhibitor. GSK-1264 binds to a site spanning the HIV-1 integrase catalytic core domain and C-terminal domain, mediates formation of an open polymer of HIV-1 integrase dimers via inhibitor-bridged contacts between adjacent dimers. GSK-1264 disrupts late-stage HIV replication by interfering with viral particle assembly. GSK-1264 stimulates inappropriate polymerization of HIV-1 integrase. GSK-1264 can be used for the research of HIV infection .
loading...
    loading...